Probable everolimus-associated severe colitis with hematochezia in a patient with metastatic hormone receptor-positive, HER2-negative breast cancer: a case report.
- DOI
- 10.3389/fphar.2026.1871050
- Published
- 2026
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1871050,
title = {Probable everolimus-associated severe colitis with hematochezia in a patient with metastatic hormone receptor-positive, HER2-negative breast cancer: a case report.},
author = {Fatayer A and Qupp SK and Morcos J and Zyadah Z and Alresheq A and Bushnaq J and Qubaja M and Laban OA},
year = {2026},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2026.1871050},
url = {https://doi.org/10.3389/fphar.2026.1871050}
}RIS
TY - JOUR TI - Probable everolimus-associated severe colitis with hematochezia in a patient with metastatic hormone receptor-positive, HER2-negative breast cancer: a case report. AU - Fatayer A AU - Qupp SK AU - Morcos J AU - Zyadah Z AU - Alresheq A AU - Bushnaq J AU - Qubaja M AU - Laban OA PY - 2026 JO - Frontiers in pharmacology DO - 10.3389/fphar.2026.1871050 UR - https://doi.org/10.3389/fphar.2026.1871050 ER -
APA
A, F., SK, Q., J, M., Z, Z., A, A., J, B., M, Q., & OA, L. (2026). Probable everolimus-associated severe colitis with hematochezia in a patient with metastatic hormone receptor-positive, HER2-negative breast cancer: a case report.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1871050
Source records
- pubmed · retrieved 2026-11-10T10:13:02.256Z